Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?

被引：2
|
作者：
Weinberg, Frank D. [1 ]
Ramnath, Nithya [1 ]
机构：
[1] Univ Michigan, Rogel Canc Ctr, Dept Internal Med, Div Hematol Oncol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2018年 / 7卷
关键词：
T-CELLS; K-RAS; INTERLEUKIN-22; EXPRESSION; LYMPHOCYTES; ACTIVATION; MIGRATION; PATHWAYS; DEFENSE;
D O I：
10.21037/tlcr.2018.09.04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S243 / S247
页数：5
相关论文
共 50 条
  • [1] IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Sternness Properties
    Khosravi, Nasim
    Caetano, Mauricio S.
    Cumpian, Amber M.
    Unver, Nese
    De la Garza Ramos, Cynthia
    Noble, Oscar
    Daliri, Soudabeh
    Hernandez, Belinda J.
    Gutierrez, Berenice A.
    Evans, Scott E.
    Hanash, Samir
    Alekseev, Andrei M.
    Yang, Yi
    Chang, Seon Hee
    Nurieva, Roza
    Kadara, Humam
    Chen, Jichao
    Ostrin, Edwin J.
    Moghaddam, Seyed Javad
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (07) : 788 - 797
  • [2] Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?
    Abdel-Rahman, Omar
    JOURNAL OF THORACIC DISEASE, 2016, 8 (08) : E794 - E795
  • [3] Gene A, upregulated by mutant KRAS, is a potential therapeutic target for lung cancer
    Kawabe, Nozomi
    Muraki, Nao
    Tanaka, Ichidai
    Sunaga, Noriaki
    Sato, Mitsuo
    CANCER SCIENCE, 2024, 115 : 1547 - 1547
  • [4] Targeting MEK in KRAS mutant lung cancer
    Jaenne, Pasi A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [5] Targeting immunosuppressive mechanisms in KRAS mutant lung cancer
    Havel, Lauren Smith
    Gao, Dingcheng
    Daniel, Jennifer S.
    Altorki, Nasser K.
    Mittal, Vivek
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S23 - S24
  • [6] KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions
    Karimi, Nastaran
    Moghaddam, Seyed Javad
    CELLS, 2023, 12 (05)
  • [7] Targeting KRAS mutant lung cancer: light at the end of the tunnel
    Drosten, Matthias
    Barbacid, Mariano
    MOLECULAR ONCOLOGY, 2022, 16 (05) : 1057 - 1071
  • [8] Improve MEK/ERK targeting in mutant KRAS lung cancer
    Chen, Zhao
    Weisberg, Ellen
    Cheng, Katherine
    Kung, Andrew L.
    Bradner, James
    Griffin, James
    Wong, Kwok-Kin
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [9] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Xiufeng Pang
    Mingyao Liu
    Chinese Journal of Cancer, 2016, 35 (11) : 571 - 573
  • [10] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Pang, Xiufeng
    Liu, Mingyao
    CHINESE JOURNAL OF CANCER, 2016, 35 : 92
12345